Use of recombinant human α2-adrenoceptors to characterize subtype selectivity of antagonist binding
- 15 August 1993
- journal article
- Published by Elsevier in European Journal of Pharmacology: Molecular Pharmacology
- Vol. 246 (3), 219-226
- https://doi.org/10.1016/0922-4106(93)90034-7
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Differential expression of two α2-adrenergic receptor subtype mRNAs in human tissuesMolecular Brain Research, 1992
- A single amino-acid difference confers major pharmacological variation between human and rodent 5-HT1B receptorsNature, 1992
- Stable expression of recombinant human α2-adrenoceptor subtypes in two mammalian cell lines: characterization with [3H]rauwolscine binding, inhibition of adenylate cyclase and RNase protection assayBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1992
- Hormonal stimulation of adenylyl cyclase through Gi-protein βγ subunitsNature, 1992
- Molecular biology of α-adrenergic receptors: implications for receptor classification and for structure-function relationshipsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1991
- Use of clonal cell lines in the analysis of neurotransmitter receptor mechanisms and functionBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1990
- [3H]RX821002: a new tool for the identification of α2A-adrenoceptorsEuropean Journal of Pharmacology, 1989
- Cloning, Sequencing, and Expression of the Gene Coding for the Human Platelet α 2 -Adrenergic ReceptorScience, 1987
- Analysis of radioligand binding experimentsJournal of Pharmacological Methods, 1985
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976